Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Biology & Therapy

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.7.11.6723PMID 18787394PMCID PMC3596869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2008

  2008cited by this paper
• Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.

  2007cited by this paper
• WTH3 is a direct target of the p53 protein

  2007cited by this paper
• Cases of Mistaken Identity

  2007cited by this paper
• Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.

  2007cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Focus on Barrett's esophagus and esophageal adenocarcinoma.

  2004cited by this paper
• Barrett's esophagus and associated adenocarcinoma in a mouse surgical model.

  2000cited by this paper
• Human cancer cell lines: fact and fantasy

  2000cited by this paper
• Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization.

  1997cited by this paper
• An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

  1994cited by this paper
• Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

  1992cited by this paper
• Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper
• Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper
• Establishment and characterization of human colorectal cancer cell lines.

  1984cited by this paper

• Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett’s Esophagus

  2024cites this paper
• CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers

  2024cites this paper
• Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma

  2022cites this paper
• Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights

  2022cites this paper
• Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-grade Dysplasia.

  2022cites this paper
• Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression

  2021cites this paper
• Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation

  2021cites this paper
• Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments

  2020cites this paper
• GEAMP, a Novel Gastroesophageal Junction Carcinoma Cell Line Derived from a Malignant Pleural Effusion

  2019cites this paper
• Subtypes of Barrett’s oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis

  2018cites this paper
• Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus.

  2018cites this paper
• Towards better models and mechanistic biomarkers for drug‐induced gastrointestinal injury

  2017cites this paper
• Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis

  2017cites this paper
• Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro

  2017influential citation
• Preclinical models of esophageal adenocarcinoma for drug development.

  2016cites this paper
• Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis

  2016cites this paper
• Whole-genome sequencing of nine esophageal adenocarcinoma cell lines

  2016cites this paper
• Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow

  2016cites this paper
• Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation

  2015cites this paper
• Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.

  2015cites this paper
• Translational research on esophageal adenocarcinoma: from cell line to clinic.

  2015cites this paper
• Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett’s esophagus

  2014cites this paper
• Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.

  2014cites this paper
• The role of HNF4α in Barrett’s metaplasia development

  2014cites this paper
• microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1

  2013cites this paper
• IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation

  2013influential citation
• Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells

  2013cites this paper
• A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett's Adenocarcinoma in a Mouse Xenograft Model

  2013cites this paper
• Characterization of a Novel Tumorigenic Esophageal Adenocarcinoma Cell Line: OANC1

  2013cites this paper
• Cell culture models for studying the development of Barrett’s esophagus: a systematic review

  2012cites this paper
• A systematic approach to therapeutic target selection in oesophago-gastric cancer

  2012cites this paper
• The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

  2012cites this paper
• Radiation Sensitivity of Esophageal Adenocarcinoma: The Contribution of the RNA-Binding Protein RNPC1 and p21-Mediated Cell Cycle Arrest to Radioresistance

  2012cites this paper
• Photocaged permeability: a new strategy for controlled drug release.

  2012cites this paper
• Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.

  2012cites this paper
• Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.

  2012influential citation
• The Human Adenocarcinoma-associated Gene, AGR2, Induces Expression of Amphiregulin through Hippo Pathway Co-activator YAP1 Activation*

  2011cites this paper
• Orthotopic Models of Esophageal Carcinoma and Their Use in Drug Discovery

  2011cites this paper
• Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis

  2011cites this paper
• The Na+/H+ Exchanger Controls Deoxycholic Acid-Induced Apoptosis by a H+-Activated, Na+-Dependent Ionic Shift in Esophageal Cells

  2011cites this paper
• Translational Research on Esophageal Cancer: From Cell Line to Clinic

  2011cites this paper
• Gene discovery and Barrett ’ s oesophagus pathogenesis

  2010cites this paper
• New models of neoplastic progression in Barrett's oesophagus.

  2010cites this paper
• Barrett's Metaplasia

  2010cites this paper
• Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.

  2010cites this paper
• Modelling Barrett's oesophagus.

  2010cites this paper
• A review of in vitro and in vivo models of oesophageal and gastric cancer

  2009cites this paper
• Cellular biometrics in the postgenomics era

  2008cites this paper
• esophagus and esophageal adenocarcinoma: transcription factors and biomarkers

  year unknowncites this paper